Cholesteryl ester transfer protein and its plasma regulator: Lipid transfer inhibitor protein

Current Opinion in Lipidology

Volumn 10, Issue 4, 1999, Pages 321-327

  Morton, Richard E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; LIPID TRANSFER PROTEIN; LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ATHEROGENESIS; HUMAN; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIPOPROTEIN SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 0032844307     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199908000-00006     Document Type: Review

References (55)

1. Desrumaux C, Athias A, Bessede G, Verges B, Farnier M, Persegol L, et al. Mass concentration of plasma phospholipid transfer protein in normolipidemic, type lla hyperlipidemic, type llb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA. Arterioscler Thromb Vasc Biol 1999; 19:266-275. This is the first clear demonstration of the fundamental differences in CETP and PLTP regulation.
2. Riemens SC, Van Tol A, Sluiter WJ, Dullaart RPF. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese type II diabetic patients. Diabetologia 1998; 41:929-934.
3. Riemens S. Van Tol A, Sluiter W, Dullaart R. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis 1998; 140:71-79.
4. Guyard-Dangremont V. Desrumaux C, Gambert P, Lallemant C, Lagrost L. Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility. Comp Biochem Physiol [B] 1998; 120:517-526.
5. Chouinard RA Jr, Luo Y, Osborne TF, Walsh A, Tall AR. Sterol regulatory element binding protein-1 activates the cholesteryl ester transfer protein gene in vivo but is not required for sterol up-regulation of gene expression. J Biol Chem 1998; 273:22409-22414.
6. Radeau T, Robb M, Lau P, Borthwick J, McPherson R. Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man. Atherosclerosis 1998; 139:369-376. This article provides strong evidence for the coupling of adipose tissue CETP synthesis and circulating CETP concentrations. Although the quantitative importance of fat tissue to plasma CETP remains to be determined, adipose tissue CETP expression mirrors closely changes in the plasma pool.
7. Radeau T, Robb M, McDonnell M, McPherson R. Preferential expression of cholesteryl ester transfer protein mRNA by stromal-vascular cells of human adipose tissue. Biochim Biophys Acta 1998; 1392:245-253.
8. Gauthier B, Robb M, McPherson R. Cholesteryl ester transfer protein gene expression during differentiation of human preadipocytes to adipocytes in primary culture. Atherosclerosis 1999: 142:301-307.
9. Benoist F, Lau P, McDonnell M, Doelle H, Milne R, McPherson R. Cholesteryl ester transfer protein mediates selective uptake of high density lipoprotein cholesteryl esters by human adipose tissue. J Biol Chem 1997; 272:23572-23577.
10. Bruce C, Chouinard RA Jr, Tall AR. Plasma lipid transfer proteins, high density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr 1998; 18:297-330.
11. Hayek T, Masucci-Magoulas L, Jiang X, Walsh A, Rubin E, Broslow JL, Tall AR. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 1995; 96:2071-2074.
12. Zhong SB, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, Tall AR. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996; 97:2917-2923.
13. Hirano K, Yamashita S, Nakajima N, Arai T, Maruyama T, Yoshida Y, et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan-marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol 1997; 17:1053-1059.
14. Tall AR. An overview of reverse cholesterol transport. Eur Heart J 1998; 19 (Suppl A):A31-A35.
15. Bruce C, Sharp DS, Tall AR, Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J Lipid Res 1998; 39:1071-1078.
16. Tall A, Sharp D, Zhong S, Hayek T, Masucci-Magoulas L, Rubin EM, Breslow JL. Cholesteryl ester transfer protein and atherogenesis. Ann NY Acad Sci 1997; 811:178-184.
17. Fielding CJ, Havel RJ. Cholesteryl ester transfer protein: Friend or foe? J Clin Invest 1996; 97:2687-2688.
18. Moriyama Y, Okamura T, Inazu A, Doi M, Iso H, Meuri Y, et al. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. Prey Med 1998; 27:659-667. This study provides important data that separates CETP deficiency from altered risk for coronary heart diseaso when plasma HDL levels are markedly elevated.
19. Plump AS, Masucci-Magoulas L, Bruce C, Bisgaier CL, Breslow JL, Tall AR. Increased atherosclerosis in apo E and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression. Arterioscler Thromb Vasc Biol 1999; 19:1105-1110. A clear illustration that CETP accentuates atherogenesis when the clearance of apolipoprotein B-containing particles is compromised.
20. Sugano M, Makino N, Sawada S, Otsuka S, Watanabe M, Okamoto H, et al. Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits. J Biol Chem 1998; 273:5033-5036. This study investigates the consequences of CETP inhibition on atherogenesis in an animal that naturally expresses CETP.
21. Bérard AM, Föger B, Remaley A, Shamburek R, Vaisman BL, Talley G, et al. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase. Nature Mod 1997; 3:744-749.
22. Hoeg JM, Santamarina-Fojo S, Bérard AM, Cornhill JF, Herderick EE, Feldman SH, et al. Overexpression of lecithin: cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc Natl Acad Sci USA 1996; 93:11445-11453.
23. Lagrost L, Perségol L, Lallemant C, Gambert P. Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins Al and All. J Biol Chem 1994; 269:3189-3197.
24. Guyard-Dangremont V, Lagrost L, Gambert P. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity. J Lipid Res 1994; 35:982-992.
25. Connolly DT, Krul ES, Heuvelman D, Glenn KC. Inhibition of cholesteryl ester transfer protein by apolipoproteins, lipopolysacchandes, and cholesteryl sulfate. Biochim Biophys Acta 1996; 1304:145-160.
26. Son YSC, Zilversmit DB. Purification and characterization of human plasma proteins that inhibit transfer activities. Biochim Biophys Acta 1984; 795:473-480.
27. Zhong S, Goldberg IJ, Bruce C, Rubin E, Breslow JL, Tall A. Human apaA-II inhibits the hydrolysis of HDL triglycoride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. J Clin Invest 1994; 94:2457-2467.
28. Moulin P, Cheung MC, Bruce C, Zhong S, Cocks T, Richardson H, Tall AR. Gender effects on the distribution of the cholesteryl ester transfer protein in apolipoprotein A-I-defined lipoprotein subpopulations. J Lipid Res 1994; 35:793-802.
29. Hayek T, Chajek-Shaul T, Walsh A, Agellon LB, Moulin P, Tall AR, Breslow JL. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-1 genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels. J Clin Invest 1992; 90:505-510.
30. Kushwaha RS, Hasan SQ, McGill HC Jr, Getz GS, Dunham RG, Kanda P. Characterization of cholesteryl ester transfer protein inhibitor from plasma of baboons (Papio sp.). J Lipid Res 1993; 34:1285-1297.
31. Cho KH, Lee JY, Choi MS, Cho JM, Lim JS, Park YB. A peptide from hog plasma that inhibits human cholesteryl ester transfer protein. Biochim Biophys Acta 1998; 1391:133-144. A small peptide similar to the N-terminus of apolipoprotein C-III is identified and its functional activity in a rabbit model is illustrated.
32. Morton RE, Zilversmit DB. A plasma inhibitor of triglyceride and cholesteryl ester transfer activities. J Biol Chem 1981; 256:11992-11995.
33. Nishide T, Tollefson JH, Albers JJ. Inhibition of lipid transfer by a unique high density lipoprotein subclass containing an inhibitor protein. J Lipid Res 1989; 30:149-158.
34. Morton RE, Greene DJ. Regulation of lipid transfer between lipoproteins by an endogenous plasma protein: selective inhibition among lipoprotein classes. J Lipid Res 1994; 35:836-847.
35. Wang X, Driscoll DM, Morton RE. Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein FJ Biol Chem 1999; 274:1814-1820. The purification, cloning and expression of LTIP are reported for the first time The identification of LTIP as apolipoprotein F establishes a function for this poorly understood apoprotein.
36. Olofsson S-O, McConathy WJ, Alaupovic P. Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma. Biochem 1978; 17:1032-1036.
37. Koran E, McConathy WJ, Alaupovic P. Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma. Biochem 1982; 21:5347-5351.
38. Day JR, Albers JJ, Gilbert TL, Whitmore TE, McConathy WJ, Wolfbauer G. Purification and molecular cloning of human apolipoprotein F. Biochem Biophys Res Commun 1994; 203:1146-1151.
39. Morton RE, Steinbrunner JV., Determination of lipid transfer inhibitor protein activity in human lipoprotein-deficient plasma. Arterioscler Thromb 1993; 13;1843-1851.
40. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991; 88:2059-2066.
41. Murakami T, Michelagnoli S, Longhi R, Gianfranceschi G, Pazzucconi F, Calabresi L, et al. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol 1995; 15:1819-1828.
42. Serdyuk AP, Morton RE. Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions: CETP has no preference for cholesteryl esters in HDL versus LDL. Arterioscler Thromb Vasc Biol 1999; 19:718-726. This study addresses the preference of CETP for LDL and HDL as substrates for lipid transfer reactions. In contrast to previous studies, these lipoproteins were shown to have equivalent capacity to donate lipids to CETP. The importance of LTIP in augmenting transfer with HDL in vivo is supported by these studies.
43. Sammett D, Tall AR. Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis. J Biol Chem 1985; 260:6687-6697.
44. Serdyuk AP, Morton RE. Lipid transfer inhibitor protein activity deficiency in normolipidemic uremic patients on continuous ambulatory peritoneal dialysis. Arterioscler Thromb Vasc Biol 1997: 17:1716-1724.
45. Main LA, Okumura-Noji K, Ohnishi T, Yokoyama S. Cholesteryl ester transfer protein reaction between plasma lipoproteins. J Biochem (Tokyo) 1998; 124:237-243. This study offers interesting insight into the importance of CETP binding to lipoproteins and CETP activity. The role of stable, non-steady state binding of CETP to lipoproteins in lipid transfer processes is seriously questioned.
46. Rajaram OV, Sawyer WH. Penetration of an emulsion surface by cholesteryl ester transfer protein. Eur Biophys J 1996; 25:31-36.
47. Weinberg RB, Cook VR, Jones JB, Kussie P, Tall AR. Interfacial properties of recombinant human cholesterol ester transfer protein. J Biol Chem 1994; 269:29588-29591.
48. Pattnaik NM, Zilversmit DB. Interaction of cholesteryl ester exchange protein with human plasma lipoproteins and phospholipid vesicles. J Biol Chem 1979; 254:2782-2786.
49. Morton RE. Binding of plasma-derived lipid transfer protein to lipoprotein substrates: the role of binding in the lipid transfer process. J Biol Chem 1985; 260:12593-12599.
50. Jiang X, Bruce C, Cocke T, Wang S, Boguski M, Tall AR. Point mutagenesis of positively charged amino acids of cholesteryl ester transfer protein: conserved residues within the lipid transfer/lipopolysaccharide binding protein gene family essential for function. Biochemistry 1995; 34:7258-7263.
51. Morton RE, Greene DJ. Enhanced detection of lipid transfer inhibitor protein activity by an assay involving only low density lipoprotein. J Lipid Res 1994; 35:2094-2099.
52. Morton RE, Greene DJ. Suppression of lipid transfer inhibitor protein activity by oleats-a novel mechanism of cholesteryl ester transfer protein regulation by plasma free fatty acids. Arterioscler Thromb Vasc Biol 1997; 17:3041-3048. This study illustrates the exquisite sensitivity of CETP and LTIP to elevated free fatty acid content. Evidence that LTIP activity is suppressed by very low free fatty acids suggests that the activity of this protein may be modulated during the course of normal post-prandiol metabolism.
53. Braschi S, Masson D, Rostoker G, Florentin E, Athias A, Martin C, et al. Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome. Arterioscler Thromb Vasc Biol 1997; 17:2559-2567.
54. Stalenhoef AFH, Malloy MJ, Kane JP, Havel RJ. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. Proc Natl Acad Sci USA 1984; 81:1839-1843.
55. Shen BW, Scanu AM, Kezdy FJ. Structure of human serum lipoproteins inferred from compositional analysis. Proc Natl Acad Sci USA 1977; 74:837-841.